Provider
The digital therapeutic is designed to treat children ages 8 to 12 with ADHD, but the two studies announced this week will focus on an adult population.
Roundup: 'On-the-spot' COVID-19 test receives CE Mark, Thriva launches women's hormones test and mo…
Also, startup creates wearable tech to tackle head injuries in sport.
This week's top stories include U.S. Anesthesia Partners alleging UnitedHealthcare is "like a boa constrictor squeezing USAP-TX from all sides" and Bright Health looking to strengthen its foothold in the telemedicine market.
Penn State Health's Cletis Earle talks about how the health system has managed population health during the pandemic with help from EHR tweaks, telehealth, data sharing via CommonWell and more.
Starting this month, eligible Fitbit Sense users can participate in the study, which will look into how pulse arrival time can be used to measure blood pressure.
The study found that patients using AliveCor Kardia Mobile required fewer follow-up EGCs and cardiac monitoring than their peers in the control group.
Funding will be used to gain in-human data for startup’s OxiFlow brain haemorrhage solution.
The manufacturer of the electronic artificial urinary sphincter aims to develop its device for treating urinary incontinence.
In this episode of HIT Cybersecurity, Nakia Grayson, IT security specialist at NIST, discusses infosec challenges inherent in delivering care from hospital to home – and offers resources that can help.